Financials
| Results for the year ended 31 March 2025 | Jul. 14, 2025 |
| Trading Update | Apr. 24, 2025 |
| Results for the Six Months Ended 30 September 2024 | Nov. 28, 2024 |
| Trading Update | Oct. 01, 2024 |
| Posting of the Annual Report and Notice of AGM | Aug. 16, 2024 |
| Final Results | Jul. 15, 2024 |
| Trading Update on year ended 31 March 2024 | Apr. 25, 2024 |
Proxies
| Posting of Annual Report and Notice of AGM | Aug. 28, 2025 |
| Result of AGM | Sep. 27, 2024 |
| Result of AGM | Sep. 07, 2023 |
| Notice of AGM | Aug. 10, 2023 |
| Result of AGM | Sep. 26, 2022 |
| Result of AGM | Sep. 17, 2021 |
| AGM Statement | Sep. 16, 2021 |
Ownership Update
| Director/PDMR Shareholding | Dec. 04, 2025 |
| Share Awards to Executive Directors | Aug. 29, 2025 |
| Holding(s) in Company | Aug. 06, 2025 |
| Holding(s) in Company | Jul. 17, 2025 |
| Director/PDMR Shareholding | Jul. 15, 2025 |
| Holding(s) in Company | May. 02, 2025 |
| Director/PDMR Shareholding | Apr. 28, 2025 |
Announcements
| ECOVAXXIN® MG favourable USDA safety assessment | Mar. 11, 2026 |
| Block Listing Return | Mar. 05, 2026 |
| EU launch plans for ECOVAXXIN® MS | Feb. 26, 2026 |
| Holding(s) in Company | Jan. 19, 2026 |
| ECOVAXXIN® MS EU marketing authorisation granted | Dec. 22, 2025 |
| Exercise of Share Options by Director | Dec. 18, 2025 |
| Holding(s) in Company | Dec. 09, 2025 |